<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Vietnamese cancer research &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/vietnamese-cancer-research/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 31 Oct 2025 10:18:47 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Vietnamese cancer research &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>CD73 and VEGF in Vietnamese Salivary Cancers</title>
		<link>https://bioengineer.org/cd73-and-vegf-in-vietnamese-salivary-cancers/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 31 Oct 2025 10:18:23 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CD73]]></category>
		<category><![CDATA[salivary gland carcinoma biomarkers]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<category><![CDATA[VEGF]]></category>
		<category><![CDATA[Vietnamese cancer research]]></category>
		<guid isPermaLink="false">https://bioengineer.org/cd73-and-vegf-in-vietnamese-salivary-cancers/</guid>

					<description><![CDATA[Salivary gland carcinomas, though rare, represent a complex oncological challenge due to their heterogeneous histology and often poor outcomes, particularly in advanced stages. A groundbreaking study from Vietnam has now shed new light on the molecular landscape of these malignancies, focusing on the expression of two critical biomarkers—CD73 and vascular endothelial growth factor (VEGF). This [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">289464</post-id>	</item>
	</channel>
</rss>
